Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers O > Headlines for Oncothyreon Inc. > News item |
Oncothyreon to price public sale of common stock through Cowen and Co.
Deal has 15% greenshoe; proceeds slated for general corporate purposes
By Devika Patel
Knoxville, Tenn., March 28 - Oncothyreon plans a public offering of common stock, according to a preliminary prospectus supplement filed Wednesday with the Securities and Exchange Commission. There is a 15% greenshoe.
Cowen and Co., LLC is the bookrunning manager, and Stifel, Nicolaus & Co., Inc. is the co-manager.
Proceeds will be used for general corporate purposes.
Oncothyreon is a Seattle biotechnology company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.